Cervical Cancer Vaccine May Stop Breast Cancer
Researchers at the University of New South Wales (UNSW) in Australia have discovered that the HPV vaccine may be effective in preventing breast cancer, which affects over a million women a year worldwide.
In a new article published in the British Journal of Cancer, the experts reveal that they conducted studies of breast cells and found that there were several strains of HPV present which are known to have a high risk of initiating cancer of the cervix.
A team from UNSW School of Biotechnology and Biomolecular Sciences, led by visiting professor James Lawson, declared that there was a presence of high-risk HPV in the nuclei of breast cancer epithelial cells in 21 per cent of 14 invasive ductal carcinoma (IDC) breast cancer specimens.
IDCs are invasive cancers responsible for up to 80 per cent of all breast cancers and professor Lawson told cancer insurance customers that the results may lead to further large-scale studies being conducted.
UNSW researcher Dr Noel Whitaker, a co-author of the new report, commented: “The finding that high-risk HPV is present in a significant number of breast cancers indicates they may have a causal role in many breast cancers.
“Confirming a cancer-causing role for HPV in some breast cancers establishes the possibility of preventing some breast cancers by vaccination against HPV.”
The new link may also help to clear up confusion about the role which HPV plays in the development of breast cancer.
In order to establish a more accurate result, the healthcare specialists used a technique that avoids cross-contamination which may have affected outcomes and announced that they are working on a new simpler method which will provide faster results.